Source data for Berger et al. Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins
Published: 4 April 2024| Version 1 | DOI: 10.17632/2n9gstvrsy.1
Contributor:
Stephanie BergerDescription
Source data for Berger et al. Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins.
Files
Steps to reproduce
Please see associated manuscript for detailed methods.
Categories
Cell Signaling, Biophysical Chemistry, Protein Engineering, Enzyme-Linked Immunosorbent Assay, Efficacy Study, Protein Binding
Funders
- Audacious ProjectUnited States
- Howard Hughes Medical InstituteUnited States
- Washington Research FoundationUnited States
- Center for Washington Entrepreneurial Research Evaluation & Commercialization Hub (WE-REACH)
- Mopac Biologics, Inc.
- National Institutes of HealthUnited StatesGrant ID: R01 GM092802, R01 AR067288, R35 GM147414, P30 GM124165